3//SEC Filing
GV 2016 GP, L.L.C. 3
Accession 0000899243-18-001920
CIK 0001693664other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 5:59 PM ET
Size
21.2 KB
Accession
0000899243-18-001920
Insider Transaction Report
Form 3
GV 2016 GP, L.P.
10% Owner
Holdings
- (indirect: By GV 2016, L.P.)
Series C-1 Convertible Preferred Stock
→ Common Stock (607,350 underlying)
Alphabet Inc.
10% Owner
Holdings
- (indirect: By GV 2016, L.P.)
Series C-1 Convertible Preferred Stock
→ Common Stock (607,350 underlying)
GV 2016 GP, L.L.C.
10% Owner
Holdings
- (indirect: By GV 2016, L.P.)
Series C-1 Convertible Preferred Stock
→ Common Stock (607,350 underlying)
GV 2016, L.P.
10% Owner
Holdings
- (indirect: By GV 2016, L.P.)
Series C-1 Convertible Preferred Stock
→ Common Stock (607,350 underlying)
Footnotes (2)
- [F1]The reported security is directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2016 GP, L.P., GV 2016 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- [F2]The reported security is convertible into the Issuer's Common Stock on a 1-for-1 basis at any time at the holder's election and shall automatically convert into Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
Issuer
ARMO BioSciences, Inc.
CIK 0001693664
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001722201
Filing Metadata
- Form type
- 3
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 5:59 PM ET
- Size
- 21.2 KB